Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
205TiP IMPACT: Randomized, multicenter, phase III study evaluating the efficacy of immunotherapy (atezolizumab) plus anti-VEGF therapy (bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma (HCC)
Tatsuya Yamashita, Yoshitaka Inaba, Masafumi Ikeda, Miyuki Sone, K. Yamakado, Hideyuki Nishiofuku, Kazuhiro Tsuchiya, Toshifumi Tada, Yozo Sato, Takahiro Kodama, Teiji Kuzuya, Sadahisa Ogasawara, Makoto Ueno, Hideki Iwamoto, Michihisa Moriguchi, Kazuomi Ueshima, Yoshihisa Kodama, Tetsuo Takehara, Takayuki Hamano, Masatoshi Kudo (2023). 205TiP IMPACT: Randomized, multicenter, phase III study evaluating the efficacy of immunotherapy (atezolizumab) plus anti-VEGF therapy (bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma (HCC). , 34, DOI: https://doi.org/10.1016/j.annonc.2023.10.784.
Article33 days agoFinal Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda, Takuji Torimura, Nobukazu Tanabe, Hiroshi Aikata, Namiki Izumi, Takahiro Yamasaki, Shunsuke Nojiri, Keisuke Hino, Hidetaka Tsumura, Teiji Kuzuya, Norio Isoda, Michihisa Moriguchi, Hajime Aino, Akio Ido, Naoto Kawabe, Kazuhiko Nakao, Yoshiyuki Wada, Sadahisa Ogasawara, Kenichi Yoshimura, Takuji Okusaka, Junji Furuse, Norihiro Kokudo, Kiwamu Okita, Philip J. Johnson, Yasuaki Arai (2022). Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma. , 11(4), DOI: https://doi.org/10.1159/000522547.
Article33 days agoTranscatheter arterial chemoembolization therapy in combination strategy with lenvatinib in patients with unresectable hepatocellular carcinoma (TACTICS-L) in Japan: Final analysis.
Kazuomi Ueshima, Toru Ishikawa, Issei Saeki, Naoki Morimoto, Hiroshi Aikata, Nobukazu Tanabe, Yoshitaka Inaba, Yoshiyuki Wada, Yasuteru Kondo, Masahiro Tsuda, Kazuhiko Nakao, Masafumi Ikeda, Michihisa Moriguchi, Takanori Ito, Masahiro Kobayashi, Hironori Koga, Keisuke Hino, Yoshiyuki Suzuki, Kenichi Yoshimura, Masatoshi Kudo (2022). Transcatheter arterial chemoembolization therapy in combination strategy with lenvatinib in patients with unresectable hepatocellular carcinoma (TACTICS-L) in Japan: Final analysis.. , 40(4_suppl), DOI: https://doi.org/10.1200/jco.2022.40.4_suppl.417.
Article33 days agoClinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment
Kazuomi Ueshima, Atsushi Komemushi, Takeshi Aramaki, Hideki Iwamoto, Shuntaro Obi, Yozo Sato, Toshihiro Tanaka, Kiyoshi Matsueda, Michihisa Moriguchi, Hiroya Saito, Miyuki Sone, Takuji Yamagami, Yoshitaka Inaba, Masatoshi Kudo, Yasuaki Arai (2022). Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment. , 11(5), DOI: https://doi.org/10.1159/000524893.
Article33 days agoHonokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis
Keiichiro Okuda, Atsushi Umemura, S Umemura, Seita Kataoka, Hiroyoshi Taketani, Yuya Seko, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Yoshihiro Kanbara, Jack L. Arbiser, Toshihide Shima, Takeshi Okanoue, Michael Karin, Yoshito Itoh (2021). Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis. , 13(7), DOI: https://doi.org/10.3390/cancers13071515.
Article49 days ago